Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.

patents (220)

Dec 15, 2041formulationUS 11701352
Dec 15, 2041formulationUS 11701352
Dec 15, 2041formulationUS 11701352
Nov 3, 2040formulationUS 11331315
Nov 3, 2040formulationUS 11331315
Nov 3, 2040formulationUS 11331315
Apr 6, 2034formulationUS 11648347
Apr 6, 2034formulationUS 11648347
Apr 6, 2034formulationUS 11648347
Apr 6, 2034formulationUS 11648347
Mar 8, 2034method-of-use (U-2723)US 10525057
Mar 8, 2034method-of-use (U-543)US 10525057
Mar 8, 2034method-of-use (U-2723)US 10525057
Mar 8, 2034method-of-use (U-543)US 10525057
Oct 15, 2033formulationUS 9268909
Oct 15, 2033formulationUS 9268909
Oct 15, 2033formulationUS 9268909
Oct 15, 2033formulationUS 9268909
Oct 15, 2033formulationUS 9268909
Oct 15, 2033formulationUS 9268909
Sep 24, 2033method-of-use (U-1632)US 10980803
Sep 24, 2033method-of-use (U-1632)US 10980803
Sep 24, 2033method-of-use (U-543)US 10980803
Sep 24, 2033method-of-use (U-1632)US 10980803
Sep 24, 2033method-of-use (U-3245)US 11154553
Sep 24, 2033method-of-use (U-3245)US 11154553
Sep 24, 2033method-of-use (U-3245)US 11154553
Sep 24, 2033method-of-use (U-3245)US 11154553
Sep 24, 2033method-of-use (U-814)US 11344547
Sep 24, 2033method-of-use (U-814)US 11344547
Sep 24, 2033method-of-use (U-814)US 11344547
Sep 24, 2033method-of-use (U-814)US 11344547
Sep 24, 2033method-of-use (U-1632)US 11400087
Sep 24, 2033method-of-use (U-1632)US 11400087
Sep 24, 2033method-of-use (U-1632)US 11400087
Sep 24, 2033method-of-use (U-1632)US 11400087
Aug 7, 2033formulationUS 9694008
Aug 7, 2033formulationUS 9694008
Aug 7, 2033formulationUS 9694008
Apr 23, 2033formulationUS 10517951
Apr 23, 2033formulationUS 10517951
Apr 23, 2033formulationUS 11097007
Apr 23, 2033formulationUS 11097007
Apr 23, 2033formulationUS 11638757
Apr 23, 2033formulationUS 11638757
Apr 23, 2033formulationUS 12016927
Apr 23, 2033formulationUS 12016927
Jun 13, 2032formulationUS 10517507
Jun 13, 2032formulationUS 10517507
Jun 13, 2032formulationUS 10517507
Jun 13, 2032formulationUS 10517507
Jun 13, 2032formulationUS 10517507
Jun 13, 2032formulationUS 10517507
Dec 15, 2031formulationUS 9320455
Dec 15, 2031formulationUS 9320455
Dec 15, 2031formulationUS 9320455
Dec 15, 2031formulationUS 9320455
Dec 15, 2031formulationUS 9320455
Dec 15, 2031formulationUS 9320455
Jul 11, 2031formulationUS 112293784.9y
Jul 11, 2031formulationUS 112293784.9y
Jul 11, 2031formulationUS 112293784.9y
Jul 11, 2031formulationUS 112293784.9y
Jul 11, 2031formulationUS 112293784.9y
Jul 11, 2031formulationUS 112293784.9y
Dec 18, 2030formulationUS 85472484.3y
Dec 18, 2030formulationUS 85472484.3y
Dec 18, 2030formulationUS 85472484.3y
Dec 18, 2030formulationUS 85472484.3y
Dec 18, 2030formulationUS 85472484.3y
Dec 18, 2030formulationUS 85472484.3y
Nov 25, 2030formulationUS 82589624.3y
Nov 25, 2030formulationUS 82589624.3y
Nov 25, 2030formulationUS 82589624.3y
Nov 25, 2030formulationUS 82589624.3y
Nov 25, 2030formulationUS 82589624.3y
Nov 25, 2030formulationUS 82589624.3y
Nov 17, 2030formulationUS 89614124.2y
Nov 17, 2030formulationUS 89614124.2y
Nov 17, 2030formulationUS 89614124.2y
Nov 17, 2030formulationUS 89614124.2y
Nov 17, 2030formulationUS 89614124.2y
Nov 17, 2030formulationUS 89614124.2y
Nov 4, 2030formulationUS 99419314.2y
Nov 4, 2030formulationUS 99419314.2y
Nov 4, 2030formulationUS 99419314.2y
Nov 4, 2030formulationUS 99419314.2y
Nov 4, 2030formulationUS 99419314.2y
Nov 4, 2030formulationUS 99419314.2y
Sep 15, 2030formulationUS 114644234.1y
Sep 15, 2030formulationUS 114644234.1y
Sep 15, 2030formulationUS 114644234.1y
Sep 15, 2030formulationUS 114644234.1y
Sep 15, 2030formulationUS 114644234.1y
Sep 15, 2030formulationUS 114644234.1y
Jun 21, 2030formulationUS 81140213.8y
Jun 21, 2030formulationUS 81140213.8y
Jun 21, 2030formulationUS 81140213.8y
Jun 21, 2030formulationUS 81140213.8y
Jun 21, 2030formulationUS 81140213.8y
Jun 21, 2030formulationUS 81140213.8y
Apr 27, 2030formulationUS 85454023.7y
Apr 27, 2030formulationUS 85454023.7y
Apr 27, 2030formulationUS 85454023.7y
Apr 27, 2030formulationUS 85454023.7y
Apr 27, 2030formulationUS 85454023.7y
Apr 27, 2030formulationUS 85454023.7y
Mar 29, 2030formulationUS 88477663.6y
Mar 29, 2030formulationUS 88477663.6y
Mar 29, 2030formulationUS 88477663.6y
Mar 29, 2030formulationUS 88477663.6y
Mar 29, 2030formulationUS 88477663.6y
Mar 29, 2030formulationUS 88477663.6y
Dec 15, 2029formulationUS 91495773.3y
Dec 15, 2029formulationUS 91495773.3y
Dec 15, 2029formulationUS 91495773.3y
Dec 15, 2029formulationUS 91495773.3y
Dec 15, 2029formulationUS 91495773.3y
Dec 15, 2029formulationUS 91495773.3y
Dec 5, 2029formulationUS 87181933.3y
Dec 5, 2029formulationUS 87181933.3y
Dec 5, 2029formulationUS 87181933.3y
Dec 5, 2029formulationUS 87181933.3y
Dec 5, 2029formulationUS 87181933.3y
Dec 5, 2029formulationUS 87181933.3y
Sep 15, 2029formulationUS 94333713.1y
Sep 15, 2029formulationUS 94333713.1y
Sep 15, 2029formulationUS 94333713.1y
Sep 15, 2029formulationUS 94333713.1y
Sep 15, 2029formulationUS 94333713.1y
Sep 15, 2029formulationUS 94333713.1y
Aug 19, 2029formulationUS 89450053.0y
Aug 19, 2029formulationUS 89450053.0y
Aug 19, 2029formulationUS 89450053.0y
Aug 19, 2029formulationUS 89450053.0y
Aug 19, 2029formulationUS 89450053.0y
Aug 19, 2029formulationUS 89450053.0y
Jul 26, 2029formulationUS 104411942.9y
Jul 26, 2029formulationUS 104411942.9y
Jul 26, 2029formulationUS 104411942.9y
Jul 26, 2029formulationUS 104411942.9y
Jul 26, 2029formulationUS 104411942.9y
Jul 26, 2029formulationUS 104411942.9y
Jul 6, 2029formulationUS 89562882.9y
Jul 6, 2029formulationUS 89562882.9y
Jul 6, 2029formulationUS 89562882.9y
Jul 6, 2029formulationUS 89562882.9y
Jul 6, 2029formulationUS 89562882.9y
Jul 6, 2029formulationUS 89562882.9y
Apr 9, 2029formulationUS 86748252.6y
Apr 9, 2029formulationUS 86748252.6y
Apr 9, 2029formulationUS 86748252.6y
Apr 9, 2029formulationUS 86748252.6y
Apr 9, 2029formulationUS 86748252.6y
Apr 9, 2029formulationUS 86748252.6y
Mar 5, 2029formulationUS 90607082.5y
Mar 5, 2029formulationUS 90607082.5y
Mar 5, 2029formulationUS 90607082.5y
Mar 5, 2029formulationUS 90607082.5y
Mar 5, 2029formulationUS 90607082.5y
Mar 5, 2029formulationUS 90607082.5y
Mar 5, 2029formulationUS 92580352.5y
Mar 5, 2029formulationUS 92580352.5y
Mar 5, 2029formulationUS 92580352.5y
Mar 5, 2029formulationUS 92580352.5y
Mar 5, 2029formulationUS 92580352.5y
Mar 5, 2029formulationUS 92580352.5y
Dec 16, 2028formulationUS 91195542.3y
Dec 16, 2028formulationUS 91195542.3y
Dec 16, 2028formulationUS 91195542.3y
Dec 16, 2028formulationUS 91195542.3y
Dec 16, 2028formulationUS 91195542.3y
Dec 16, 2028formulationUS 91195542.3y
Nov 19, 2027formulationUS 94445031.2y
Nov 19, 2027formulationUS 94445031.2y
Nov 19, 2027formulationUS 94445031.2y
Nov 19, 2027formulationUS 94445031.2y
Nov 19, 2027formulationUS 94445031.2y
Nov 19, 2027formulationUS 94445031.2y
Mar 2, 2027method-of-use (U-1529)US 8759350194d
Mar 2, 2027method-of-use (U-1529)US 8759350194d
Mar 2, 2027method-of-use (U-1529)US 8759350194d
Mar 2, 2027method-of-use (U-1529)US 8759350194d
Mar 2, 2027method-of-use (U-1529)US 8759350194d
Mar 2, 2027method-of-use (U-1529)US 8759350194d
Mar 2, 2027method-of-use (U-1529)US 8759350194d
Mar 2, 2027method-of-use (U-1529)US 8759350194d
Mar 2, 2027method-of-use (U-1529)US 8759350194d
Mar 2, 2027method-of-use (U-1529)US 8759350194d
Mar 2, 2027method-of-use (U-1529)US 8759350194d
Mar 2, 2027method-of-use (U-1529)US 8759350194d
Mar 2, 2027method-of-use (U-1529)US 8759350194d
Mar 2, 2027method-of-use (U-1529)US 8759350194d
Mar 2, 2027method-of-use (U-1529)US 8759350194d
Sep 14, 2026formulationUS 797806425d
Sep 14, 2026formulationUS 797806425d
Sep 14, 2026formulationUS 797806425d
Sep 14, 2026formulationUS 797806425d
Sep 14, 2026formulationUS 797806425d
Sep 14, 2026formulationUS 797806425d
Jul 28, 2026method-of-use (U-1749)US 9125939
Jul 28, 2026method-of-use (U-1749)US 9125939
Jul 28, 2026method-of-use (U-1749)US 9125939
Jul 28, 2026method-of-use (U-1749)US 9125939
Jul 28, 2026method-of-use (U-1749)US 9125939
Jul 28, 2026method-of-use (U-1749)US 9125939
Jul 28, 2026method-of-use (U-1749)US 9125939
Jul 28, 2026method-of-use (U-1749)US 9125939
Jul 28, 2026method-of-use (U-1749)US 9125939
Jul 28, 2026method-of-use (U-1749)US 9125939
Jul 28, 2026method-of-use (U-1749)US 9125939
Jul 28, 2026method-of-use (U-1749)US 9125939
Jul 28, 2026method-of-use (U-1749)US 9125939
Jul 28, 2026method-of-use (U-1749)US 9125939
Apr 28, 2026formulationUS 11476952
Apr 28, 2026formulationUS 11476952
Apr 28, 2026formulationUS 11476952
Apr 28, 2026formulationUS 11476952
Apr 28, 2026formulationUS 11476952
Apr 28, 2026formulationUS 11476952

News(0)

no news has mentioned this drug yet

Data sources

openFDA · ClinicalTrials.gov

last refreshed 44m ago

Found something off?

comments(0)

5-min edit window · permanent after that

no comments yet — first sniff?

drug

save

aripiprazole LA

Marketedupdated 3mo ago

by Otsuka America Pharmaceutical Inc

Approved

community read0 votes

🐶 often sniffed alongside

top 3

indications

investigational

Schizophrenia

all catalysts(19)

approval · 19

Feb 28, 2013

approval

13y ago

ABILIFY MAINTENA KIT (ARIPIPRAZOLE) — FDA approval

ABILIFY MAINTENA KIT (ARIPIPRAZOLE) — FDA approval

ABILIFY MAINTENA KIT (ARIPIPRAZOLE) — FDA approval

ABILIFY MAINTENA KIT (ARIPIPRAZOLE) — FDA approval

ABILIFY MAINTENA KIT (ARIPIPRAZOLE) — FDA approval

ABILIFY MAINTENA KIT (ARIPIPRAZOLE) — FDA approval

ABILIFY MAINTENA KIT (ARIPIPRAZOLE) — FDA approval

ABILIFY MAINTENA KIT (ARIPIPRAZOLE) — FDA approval

ABILIFY MAINTENA KIT (ARIPIPRAZOLE) — FDA approval

ABILIFY MAINTENA KIT (ARIPIPRAZOLE) — FDA approval

ABILIFY MAINTENA KIT (ARIPIPRAZOLE) — FDA approval

ABILIFY MAINTENA KIT (ARIPIPRAZOLE) — FDA approval

ABILIFY MAINTENA KIT (ARIPIPRAZOLE) — FDA approval

ABILIFY MAINTENA KIT (ARIPIPRAZOLE) — FDA approval

ABILIFY MAINTENA KIT (ARIPIPRAZOLE) — FDA approval

ABILIFY MAINTENA KIT (ARIPIPRAZOLE) — FDA approval

ARIPIPRAZOLE — FDA approval

ABILIFY MAINTENA KIT (ARIPIPRAZOLE) — FDA approval

ARIPIPRAZOLE — FDA approval

aripiprazole LA

→

view all 19 catalysts →

Trials studying aripiprazole LA

phase3Study to Evaluate Efficacy and Safety of Roluperidone in Adult Subjects With Negative Symptoms and Stable Positive Symptoms of Schizophrenia and to Evaluate the Relapse Rate of Roluperidone and Antipsychotic Medicationsrecruitingn=380
phase2A Study Assessing the Efficacy and Safety of HS-10380 in Hospitalized Adults With Acute Schizophreniacompletedn=363
N/ASteady-state Bioequivalence Study of Aripiprazole for Injection in Patients With Schizophrenia.not yet recruitingn=116
—Long-term Antipsychotic Pediatric Safety Trialcompletedn=509
phase4C-Cog in Early Course Schizophrenia Studyterminatedn=1
phase1Whole Blood and Plasma Sample Collection for the Development of Antipsychotic Immunoassays From Participants Taking Aripiprazole, Olanzapine, Paliperidone, or Risperidonecompletedn=81
phase2RP5063 in Subjects With Schizophrenia or Schizoaffective Disordercompletedn=234
phase3A Study to Compare Disease Progression and Modification Following Treatment With Paliperidone Palmitate Long-Acting Injection or Oral Antipsychotics in Participant's With Recent-onset Schizophrenia or Schizophreniformcompletedn=337

more trials →

Patent cliff

source: FDA Orange Book

first barrier falls

Sep 14, 2026

25 days

Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.

patents (220)

Dec 15, 2041formulationUS 11701352
Dec 15, 2041formulationUS 11701352
Dec 15, 2041formulationUS 11701352
Nov 3, 2040formulationUS 11331315
Nov 3, 2040formulationUS 11331315
Nov 3, 2040formulationUS 11331315
Apr 6, 2034formulationUS 11648347
Apr 6, 2034formulationUS 11648347
Apr 6, 2034formulationUS 11648347
Apr 6, 2034formulationUS 11648347
Mar 8, 2034method-of-use (U-2723)US 10525057
Mar 8, 2034method-of-use (U-543)US 10525057
Mar 8, 2034method-of-use (U-2723)US 10525057
Mar 8, 2034method-of-use (U-543)US 10525057
Oct 15, 2033formulationUS 9268909
Oct 15, 2033formulationUS 9268909
Oct 15, 2033formulationUS 9268909
Oct 15, 2033formulationUS 9268909
Oct 15, 2033formulationUS 9268909
Oct 15, 2033formulationUS 9268909
Sep 24, 2033method-of-use (U-1632)US 10980803
Sep 24, 2033method-of-use (U-1632)US 10980803
Sep 24, 2033method-of-use (U-543)US 10980803
Sep 24, 2033method-of-use (U-1632)US 10980803
Sep 24, 2033method-of-use (U-3245)US 11154553
Sep 24, 2033method-of-use (U-3245)US 11154553
Sep 24, 2033method-of-use (U-3245)US 11154553
Sep 24, 2033method-of-use (U-3245)US 11154553
Sep 24, 2033method-of-use (U-814)US 11344547
Sep 24, 2033method-of-use (U-814)US 11344547
Sep 24, 2033method-of-use (U-814)US 11344547
Sep 24, 2033method-of-use (U-814)US 11344547
Sep 24, 2033method-of-use (U-1632)US 11400087
Sep 24, 2033method-of-use (U-1632)US 11400087
Sep 24, 2033method-of-use (U-1632)US 11400087
Sep 24, 2033method-of-use (U-1632)US 11400087
Aug 7, 2033formulationUS 9694008
Aug 7, 2033formulationUS 9694008
Aug 7, 2033formulationUS 9694008
Apr 23, 2033formulationUS 10517951
Apr 23, 2033formulationUS 10517951
Apr 23, 2033formulationUS 11097007
Apr 23, 2033formulationUS 11097007
Apr 23, 2033formulationUS 11638757
Apr 23, 2033formulationUS 11638757
Apr 23, 2033formulationUS 12016927
Apr 23, 2033formulationUS 12016927
Jun 13, 2032formulationUS 10517507
Jun 13, 2032formulationUS 10517507
Jun 13, 2032formulationUS 10517507
Jun 13, 2032formulationUS 10517507
Jun 13, 2032formulationUS 10517507
Jun 13, 2032formulationUS 10517507
Dec 15, 2031formulationUS 9320455
Dec 15, 2031formulationUS 9320455
Dec 15, 2031formulationUS 9320455
Dec 15, 2031formulationUS 9320455
Dec 15, 2031formulationUS 9320455
Dec 15, 2031formulationUS 9320455
Jul 11, 2031formulationUS 112293784.9y
Jul 11, 2031formulationUS 112293784.9y
Jul 11, 2031formulationUS 112293784.9y
Jul 11, 2031formulationUS 112293784.9y
Jul 11, 2031formulationUS 112293784.9y
Jul 11, 2031formulationUS 112293784.9y
Dec 18, 2030formulationUS 85472484.3y
Dec 18, 2030formulationUS 85472484.3y
Dec 18, 2030formulationUS 85472484.3y
Dec 18, 2030formulationUS 85472484.3y
Dec 18, 2030formulationUS 85472484.3y
Dec 18, 2030formulationUS 85472484.3y
Nov 25, 2030formulationUS 82589624.3y
Nov 25, 2030formulationUS 82589624.3y
Nov 25, 2030formulationUS 82589624.3y
Nov 25, 2030formulationUS 82589624.3y
Nov 25, 2030formulationUS 82589624.3y
Nov 25, 2030formulationUS 82589624.3y
Nov 17, 2030formulationUS 89614124.2y
Nov 17, 2030formulationUS 89614124.2y
Nov 17, 2030formulationUS 89614124.2y
Nov 17, 2030formulationUS 89614124.2y
Nov 17, 2030formulationUS 89614124.2y
Nov 17, 2030formulationUS 89614124.2y
Nov 4, 2030formulationUS 99419314.2y
Nov 4, 2030formulationUS 99419314.2y
Nov 4, 2030formulationUS 99419314.2y
Nov 4, 2030formulationUS 99419314.2y
Nov 4, 2030formulationUS 99419314.2y
Nov 4, 2030formulationUS 99419314.2y
Sep 15, 2030formulationUS 114644234.1y
Sep 15, 2030formulationUS 114644234.1y
Sep 15, 2030formulationUS 114644234.1y
Sep 15, 2030formulationUS 114644234.1y
Sep 15, 2030formulationUS 114644234.1y
Sep 15, 2030formulationUS 114644234.1y
Jun 21, 2030formulationUS 81140213.8y
Jun 21, 2030formulationUS 81140213.8y
Jun 21, 2030formulationUS 81140213.8y
Jun 21, 2030formulationUS 81140213.8y
Jun 21, 2030formulationUS 81140213.8y
Jun 21, 2030formulationUS 81140213.8y
Apr 27, 2030formulationUS 85454023.7y
Apr 27, 2030formulationUS 85454023.7y
Apr 27, 2030formulationUS 85454023.7y
Apr 27, 2030formulationUS 85454023.7y
Apr 27, 2030formulationUS 85454023.7y
Apr 27, 2030formulationUS 85454023.7y
Mar 29, 2030formulationUS 88477663.6y
Mar 29, 2030formulationUS 88477663.6y
Mar 29, 2030formulationUS 88477663.6y
Mar 29, 2030formulationUS 88477663.6y
Mar 29, 2030formulationUS 88477663.6y
Mar 29, 2030formulationUS 88477663.6y
Dec 15, 2029formulationUS 91495773.3y
Dec 15, 2029formulationUS 91495773.3y
Dec 15, 2029formulationUS 91495773.3y
Dec 15, 2029formulationUS 91495773.3y
Dec 15, 2029formulationUS 91495773.3y
Dec 15, 2029formulationUS 91495773.3y
Dec 5, 2029formulationUS 87181933.3y
Dec 5, 2029formulationUS 87181933.3y
Dec 5, 2029formulationUS 87181933.3y
Dec 5, 2029formulationUS 87181933.3y
Dec 5, 2029formulationUS 87181933.3y
Dec 5, 2029formulationUS 87181933.3y
Sep 15, 2029formulationUS 94333713.1y
Sep 15, 2029formulationUS 94333713.1y
Sep 15, 2029formulationUS 94333713.1y
Sep 15, 2029formulationUS 94333713.1y
Sep 15, 2029formulationUS 94333713.1y
Sep 15, 2029formulationUS 94333713.1y
Aug 19, 2029formulationUS 89450053.0y
Aug 19, 2029formulationUS 89450053.0y
Aug 19, 2029formulationUS 89450053.0y
Aug 19, 2029formulationUS 89450053.0y
Aug 19, 2029formulationUS 89450053.0y
Aug 19, 2029formulationUS 89450053.0y
Jul 26, 2029formulationUS 104411942.9y
Jul 26, 2029formulationUS 104411942.9y
Jul 26, 2029formulationUS 104411942.9y
Jul 26, 2029formulationUS 104411942.9y
Jul 26, 2029formulationUS 104411942.9y
Jul 26, 2029formulationUS 104411942.9y
Jul 6, 2029formulationUS 89562882.9y
Jul 6, 2029formulationUS 89562882.9y
Jul 6, 2029formulationUS 89562882.9y
Jul 6, 2029formulationUS 89562882.9y
Jul 6, 2029formulationUS 89562882.9y
Jul 6, 2029formulationUS 89562882.9y
Apr 9, 2029formulationUS 86748252.6y
Apr 9, 2029formulationUS 86748252.6y
Apr 9, 2029formulationUS 86748252.6y
Apr 9, 2029formulationUS 86748252.6y
Apr 9, 2029formulationUS 86748252.6y
Apr 9, 2029formulationUS 86748252.6y
Mar 5, 2029formulationUS 90607082.5y
Mar 5, 2029formulationUS 90607082.5y
Mar 5, 2029formulationUS 90607082.5y
Mar 5, 2029formulationUS 90607082.5y
Mar 5, 2029formulationUS 90607082.5y
Mar 5, 2029formulationUS 90607082.5y
Mar 5, 2029formulationUS 92580352.5y
Mar 5, 2029formulationUS 92580352.5y
Mar 5, 2029formulationUS 92580352.5y
Mar 5, 2029formulationUS 92580352.5y
Mar 5, 2029formulationUS 92580352.5y
Mar 5, 2029formulationUS 92580352.5y
Dec 16, 2028formulationUS 91195542.3y
Dec 16, 2028formulationUS 91195542.3y
Dec 16, 2028formulationUS 91195542.3y
Dec 16, 2028formulationUS 91195542.3y
Dec 16, 2028formulationUS 91195542.3y
Dec 16, 2028formulationUS 91195542.3y
Nov 19, 2027formulationUS 94445031.2y
Nov 19, 2027formulationUS 94445031.2y
Nov 19, 2027formulationUS 94445031.2y
Nov 19, 2027formulationUS 94445031.2y
Nov 19, 2027formulationUS 94445031.2y
Nov 19, 2027formulationUS 94445031.2y
Mar 2, 2027method-of-use (U-1529)US 8759350194d
Mar 2, 2027method-of-use (U-1529)US 8759350194d
Mar 2, 2027method-of-use (U-1529)US 8759350194d
Mar 2, 2027method-of-use (U-1529)US 8759350194d
Mar 2, 2027method-of-use (U-1529)US 8759350194d
Mar 2, 2027method-of-use (U-1529)US 8759350194d
Mar 2, 2027method-of-use (U-1529)US 8759350194d
Mar 2, 2027method-of-use (U-1529)US 8759350194d
Mar 2, 2027method-of-use (U-1529)US 8759350194d
Mar 2, 2027method-of-use (U-1529)US 8759350194d
Mar 2, 2027method-of-use (U-1529)US 8759350194d
Mar 2, 2027method-of-use (U-1529)US 8759350194d
Mar 2, 2027method-of-use (U-1529)US 8759350194d
Mar 2, 2027method-of-use (U-1529)US 8759350194d
Mar 2, 2027method-of-use (U-1529)US 8759350194d
Sep 14, 2026formulationUS 797806425d
Sep 14, 2026formulationUS 797806425d
Sep 14, 2026formulationUS 797806425d
Sep 14, 2026formulationUS 797806425d
Sep 14, 2026formulationUS 797806425d
Sep 14, 2026formulationUS 797806425d
Jul 28, 2026method-of-use (U-1749)US 9125939
Jul 28, 2026method-of-use (U-1749)US 9125939
Jul 28, 2026method-of-use (U-1749)US 9125939
Jul 28, 2026method-of-use (U-1749)US 9125939
Jul 28, 2026method-of-use (U-1749)US 9125939
Jul 28, 2026method-of-use (U-1749)US 9125939
Jul 28, 2026method-of-use (U-1749)US 9125939
Jul 28, 2026method-of-use (U-1749)US 9125939
Jul 28, 2026method-of-use (U-1749)US 9125939
Jul 28, 2026method-of-use (U-1749)US 9125939
Jul 28, 2026method-of-use (U-1749)US 9125939
Jul 28, 2026method-of-use (U-1749)US 9125939
Jul 28, 2026method-of-use (U-1749)US 9125939
Jul 28, 2026method-of-use (U-1749)US 9125939
Apr 28, 2026formulationUS 11476952
Apr 28, 2026formulationUS 11476952
Apr 28, 2026formulationUS 11476952
Apr 28, 2026formulationUS 11476952
Apr 28, 2026formulationUS 11476952
Apr 28, 2026formulationUS 11476952

News(0)

no news has mentioned this drug yet

Data sources

openFDA · ClinicalTrials.gov

last refreshed 44m ago

Found something off?

comments(0)

5-min edit window · permanent after that

no comments yet — first sniff?

aripiprazole LA

🐶 often sniffed alongside

indications

all catalysts(19)

Trials studying aripiprazole LA

Patent cliff

patents (220)

News(0)

Report a data issue

comments(0)

aripiprazole LA

🐶 often sniffed alongside

indications

all catalysts(19)

Trials studying aripiprazole LA

Patent cliff

patents (220)

News(0)

Report a data issue

comments(0)